[18] A Multi-SNP Locus-Association Method Reveals a Substantial Fraction of the Missing Heritability. Ehret GB, Lamparter D, Hoggart CJ; Genetic Investigation of Anthropometric Traits Consortium, Whittaker JC, Beckmann JS, Kutalik Z. Am J Hum Genet. 2012 Nov 2;91(5):863-71.
[17] A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders. Zufferey F, Sherr EH, Beckmann ND, Hanson E, Maillard AM, Hippolyte L, Macé A, Ferrari C, Kutalik Z, Andrieux J, Aylward E, Barker M, Bernier R, Bouquillon S, Conus P, Delobel B, Faucett WA, Goin-Kochel RP, Grant E, Harewood L, Hunter JV, Lebon S, Ledbetter DH, Martin CL, Männik K, Martinet D, Mukherjee P, Ramocki MB, Spence SJ, Steinman KJ, Tjernagel J, Spiro JE, Reymond A, Beckmann JS, Chung WK, Jacquemont S; on behalf of the Simons VIP Consortium,; on behalf of the 16p11.2 European Consortium. J Med Genet. 2012 Oct;49(10):660-668.
[16] FTO genotype is associated with phenotypic variability of body mass index. Yang et al. Nature. 2012 Oct 11;490(7419):267-72.
[15] Integration of Genome-Wide Association Studies with Biological Knowledge Identifies Six Novel Genes Related to Kidney Function. Chasman et al. Hum Mol Gen. 2012 Dec 15;21(24):5329-43.
[14] Genome-wide meta-analysis of common variant differences between men and women. Boraska et al. Hum Mol Gen. 2012 Nov 1;21(21):4805-15.
[13] Genome-Wide Association Study Identifies Variants Associated with Progression of Liver Fibrosis from HCV Infection. Patin E*, Kutalik Z*, Guergnon J, Bibert S, Nalpas B, Jouanguy E, Munteanu M, Bousquet L, Argiro L, Halfon P, Boland A, Müllhaupt B, Semela D, Dufour JF, Heim MH, Moradpour D, Cerny A, Malinverni R, Hirsch H, Martinetti G, Suppiah V, Stewart G, Booth DR, George J, Casanova JL, Bréchot C, Rice CM, Talal AH, Jacobson IM, Bourlière M, Theodorou I, Poynard T, Negro F, Pol S, Bochud PY*, Abel L*. Gastroenterology. 2012 Nov;143(5):1244-52.e1-12.
[12] A Genetic Validation Study Reveals a Role of Vitamin D Metabolism in the Response to Interferon-Alfa-Based Therapy of Chronic Hepatitis C. Lange CM, Bibert S, Kutalik Z, Burgisser P, Cerny A, Dufour JF, Geier A, Gerlach TJ, Heim MH, Malinverni R, Negro F, Regenass S, Badenhoop K, Bojunga J, Sarrazin C, Zeuzem S, Müller T, Berg T, Bochud PY, Moradpour D; the Swiss Hepatitis C Cohort Study Group. PLoS One. 2012;7(7):e40159.
[11] Identification and validation of copy number variants using SNP genotyping arrays from a large clinical cohort. Valsesia A, Stevenson BJ, Waterworth DM, Mooser V, Vollenweider P, Waeber G, Jongeneel CV, Beckmann JS, Kutalik Z* , Bergmann S* BMC Genomics. 2012 Jun 15;13(1):241.
[10] Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension. Guessous I, Dobrinas M, Kutalik Z, Pruijm M, Ehret G, Maillard M, Bergmann S, Beckmann JS, Cusi D, Rizzi F, Cappuccio F, Cornuz J, Paccaud F, Mooser V, Gaspoz JM, Waeber G, Burnier M, Vollenweider P, Eap CB, Bochud M. Hum Mol Genet. 2012 Jul 15;21(14):3283-92.
[9] Genome-wide association study to identify common variants associated with brachial circumference: a meta-analysis of 14 cohorts. Boraska et al. PLoS One. 2012;7(3):e31369.
[8] Genome-wide association and functional follow-up reveals new loci for kidney function. Pattaro et al. PLoS Genet. 2012 Mar;8(3):e1002584.
[6] Comparative modular analysis of gene expression in vertebrate organs. Piasecka B, Kutalik Z, Roux J, Bergmann S, Robinson-Rechavi M. BMC Genomics. 2012 Mar 29;13:124.
[5] No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels. Scott et al. Diabetes. 2012 May;61(5):1291-6.
[4] Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Stolk et al. Nat Genet. 2012 Jan 22;44(3):260-8.
[3] Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase. Salvi E, Kutalik Z, Glorioso N, Benaglio P, Frau F, Kuznetsova T, Arima H, Hoggart C, Tichet J, Nikitin YP, Conti C, Seidlerova J, Tikhonoff V, Stolarz-Skrzypek K, Johnson T, Devos N, Zagato L, Guarrera S, Zaninello R, Calabria A, Stancanelli B, Troffa C, Thijs L, Rizzi F, Simonova G, Lupoli S, Argiolas G, Braga D, D’Alessio MC, Ortu MF, Ricceri F, Mercurio M, Descombes P, Marconi M, Chalmers J, Harrap S, Filipovsky J, Bochud M, Iacoviello L, Ellis J, Stanton AV, Laan M, Padmanabhan S, Dominiczak AF, Samani NJ, Melander O, Jeunemaitre X, Manunta P, Shabo A, Vineis P, Cappuccio FP, Caulfield MJ, Matullo G, Rivolta C, Munroe PB, Barlassina C, Staessen JA, Beckmann JS, Cusi D. Hypertension. 2012 Feb;59(2):248-55.
[2] IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes. Bochud PY, Bibert S, Kutalik Z, Patin E, Guergnon J, Nalpas B, Goossens N, Kuske L, Müllhaupt B, Gerlach T, Heim MH, Moradpour D, Cerny A, Malinverni R, Regenass S, Dollenmaier G, Hirsch H, Martinetti G, Gorgiewski M, Bourlière M, Poynard T, Theodorou I, Abel L, Pol S, Dufour JF, Negro F; Swiss Hepatitis C Cohort Study Group; ANRS HC EP 26 Genoscan Study Group. Hepatology. 2012 Feb;55(2):384-94. doi: 10.1002/hep.24678.
[1] Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy. Lange CM, Kutalik Z, Morikawa K, Bibert S, Cerny A, Dollenmaier G, Dufour JF, Gerlach TJ, Heim MH, Malinverni R, Müllhaupt B, Negro F, Moradpour D, Bochud PY; Swiss Hepatitis C Cohort Study Group. Hepatology. 2012 Apr;55(4):1038-47. doi: 10.1002/hep.24787. Epub 2012 Feb 9.